TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Hedge Fund News: Ray Dalio, Bill Ackman, PetMed Express, Inc. (PETS), Opko Health Inc. (OPK), and More - Insider Monkey
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
/cloudfront-us-east-2.images.arcpublishing.com/reuters/TXPLYGRUT5KWNMUFX5GWIKKLXM.jpg "TEVA.TA - | Stock Price & Latest News | Reuters")
TEVA.TA - | Stock Price & Latest News | Reuters
UPDATED: Ex-Pfizer employee who leaked M&A targets pleads guilty to insider trading charges | Fierce Pharma
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
IDF Spokesperson: 199 hostages held in Gaza - Globes
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
SEC charges former Pfizer employee with insider trading
Two Israelis accused of Mobileye insider trading | The Times of Israel
Patrycja Cybinska on LinkedIn: #womenempowerment #femtech #repharma2024
TEVA PHARMACEUTICALS USA, INC. | Reuters
Teva Offering to Buy Rival Mylan for $40 Billion
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Opening Bell: 10.3.23 - Dealbreaker
/archive-images.prod.global.a201836.reutersmedia.net/2016/12/15/LYNXMPECBE17O.JPG "U.S. states sue Mylan, Teva, others for fixing drug prices | Reuters")
U.S. states sue Mylan, Teva, others for fixing drug prices | Reuters
Israeli professor settles Mobileye insider trading case in U.S.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/TMPHJJGVDNNJ3PTCQYHM3VRWKQ.jpg "Teva to pay $225 mln, divest cholesterol drug to settle price-fixing charges | Reuters")
Teva to pay $225 mln, divest cholesterol drug to settle price-fixing charges | Reuters
Billionaire Steve Cohen leads $27.5 million investment in MediWound | Ctech
